Back to Journals » OncoTargets and Therapy » Volume 11

CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression

Total article views   Abstract views HTML views PDF downloads Totals
4,033 Dovepress* 3,351 386+ 403 3,737
PubMed Central* 0 296 65 296
Totals 3,351 682 468 4,033
*Since 25 June 2018
+Since July 2016

View citations on PubMed Central and Google Scholar